FI960303A0 - D-vitamiinianalogeja - Google Patents

D-vitamiinianalogeja

Info

Publication number
FI960303A0
FI960303A0 FI960303A FI960303A FI960303A0 FI 960303 A0 FI960303 A0 FI 960303A0 FI 960303 A FI960303 A FI 960303A FI 960303 A FI960303 A FI 960303A FI 960303 A0 FI960303 A0 FI 960303A0
Authority
FI
Finland
Prior art keywords
alpha
azide
optionally substituted
group
vitamin
Prior art date
Application number
FI960303A
Other languages
English (en)
Swedish (sv)
Other versions
FI960303A (fi
FI113535B (fi
Inventor
Robert Henry Hesse
Malathi Ramgopal
Gaddam Subba Reddy
Sundara Katugam Srinivas Setty
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of FI960303A0 publication Critical patent/FI960303A0/fi
Publication of FI960303A publication Critical patent/FI960303A/fi
Application granted granted Critical
Publication of FI113535B publication Critical patent/FI113535B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
FI960303A 1993-07-23 1996-01-22 Menetelmä terapeuttisesti käyttökelpoisten D-vitamiinianalogien valmistamiseksi FI113535B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939315253A GB9315253D0 (en) 1993-07-23 1993-07-23 Chemical compounds
GB9315253 1993-07-23
GB9401587 1994-07-22
PCT/GB1994/001587 WO1995003273A1 (en) 1993-07-23 1994-07-22 Vitamin d analogues

Publications (3)

Publication Number Publication Date
FI960303A0 true FI960303A0 (fi) 1996-01-22
FI960303A FI960303A (fi) 1996-03-22
FI113535B FI113535B (fi) 2004-05-14

Family

ID=10739292

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960303A FI113535B (fi) 1993-07-23 1996-01-22 Menetelmä terapeuttisesti käyttökelpoisten D-vitamiinianalogien valmistamiseksi

Country Status (20)

Country Link
US (2) US5872140A (fi)
EP (1) EP0710227B1 (fi)
JP (1) JPH09500637A (fi)
KR (1) KR100321415B1 (fi)
CN (1) CN1043883C (fi)
AT (1) ATE172451T1 (fi)
AU (1) AU690565B2 (fi)
CA (1) CA2167837A1 (fi)
CZ (1) CZ20796A3 (fi)
DE (1) DE69414115T2 (fi)
DK (1) DK0710227T3 (fi)
ES (1) ES2125466T3 (fi)
FI (1) FI113535B (fi)
GB (1) GB9315253D0 (fi)
HU (1) HU221597B (fi)
IL (1) IL110415A (fi)
NO (1) NO314453B1 (fi)
NZ (1) NZ268659A (fi)
WO (1) WO1995003273A1 (fi)
ZA (1) ZA945427B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP1220676B1 (en) 1999-09-29 2005-05-04 Colotech A/S Prevention of colorectal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
ES2347045T3 (es) * 2002-11-04 2010-10-25 Ocean Nutrition Canada Limited Microcapsulas que tienen multiples cortezas, y metodo para su preparacion.
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
EP1848729A2 (en) * 2005-01-27 2007-10-31 Ocean Nutrition Canada Limited Chromium-fatty acid compounds and methods of making and using thereof
DE602006011127D1 (de) * 2005-01-27 2010-01-28 Ocean Nutrition Canada Ltd Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
WO2007120500A2 (en) * 2006-04-07 2007-10-25 Ocean Nutrition Canada Ltd. Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
EP2040682B1 (en) * 2006-06-05 2017-07-26 DSM Nutritional Products AG Microcapsules with improved shells
EP2124905B1 (en) 2007-01-10 2016-09-07 DSM Nutritional Products AG Microcapsules including pea protein
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
CA2981549A1 (en) * 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
SG10201404883YA (en) 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
AU2014274099A1 (en) 2013-05-29 2015-12-24 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin D
CN104926739B (zh) * 2015-06-09 2017-06-27 南京理工大学 基于氮杂环修饰的维生素d2衍生物、合成及应用
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3276167D1 (en) * 1981-11-02 1987-06-04 Res Inst Medicine Chem Intermediates in the synthesis of vitamin d derivatives
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them
US5446635A (en) * 1993-06-24 1995-08-29 Quarton, Inc. Laser assembly for marking a line on a workpiece for guiding a cutting tool

Also Published As

Publication number Publication date
CA2167837A1 (en) 1995-02-02
CN1043883C (zh) 1999-06-30
FI960303A (fi) 1996-03-22
HU9600136D0 (en) 1996-03-28
DK0710227T3 (da) 1999-06-28
WO1995003273A1 (en) 1995-02-02
DE69414115D1 (de) 1998-11-26
NO960251L (no) 1996-03-22
HU221597B (hu) 2002-11-28
GB9315253D0 (en) 1993-09-08
AU7193994A (en) 1995-02-20
ATE172451T1 (de) 1998-11-15
CN1129441A (zh) 1996-08-21
US5872140A (en) 1999-02-16
ES2125466T3 (es) 1999-03-01
NO960251D0 (no) 1996-01-22
KR100321415B1 (ko) 2002-11-13
IL110415A0 (en) 1996-03-31
EP0710227B1 (en) 1998-10-21
ZA945427B (en) 1995-08-24
JPH09500637A (ja) 1997-01-21
NZ268659A (en) 1996-09-25
CZ20796A3 (en) 1996-10-16
EP0710227A1 (en) 1996-05-08
IL110415A (en) 2000-01-31
HUT73846A (en) 1996-09-30
AU690565B2 (en) 1998-04-30
DE69414115T2 (de) 1999-04-08
NO314453B1 (no) 2003-03-24
US6013814A (en) 2000-01-11
FI113535B (fi) 2004-05-14

Similar Documents

Publication Publication Date Title
FI960303A0 (fi) D-vitamiinianalogeja
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
DE3574014D1 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
NO995075D0 (no) Steroid-sulfataseinhibitorer
ES2160408T3 (es) Trifluorfenil-triazolpirimidinas fungicidas.
AU1026599A (en) Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
IL74497A0 (en) Pharmaceutical compositions and phenyl carbamate derivatives
PT831837E (pt) Utilizacao de esqualamina no fabrico de um medicamento para inibicao de nhe
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
NO981393D0 (no) Guanidinoproteasehemmere
ES2132651T3 (es) Derivados amidicos de la vitamina d.
GB2324091A (en) Metalloproteinase inhibitors
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
AU6722498A (en) Disubstituted biphenyloxazolines
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FI960588A (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
ITMI931808A1 (it) Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico

Legal Events

Date Code Title Description
MA Patent expired